betamethasone prenatal
Selected indexed studies
- Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes. (Front Endocrinol (Lausanne), 2020) [PMID:32849311]
- Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort. (J Diabetes Res, 2022) [PMID:35308094]
- Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids: The ALPS Follow-Up Study. (JAMA, 2024) [PMID:38656759]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes. (2020) pubmed
- Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort. (2022) pubmed
- Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids: The ALPS Follow-Up Study. (2024) pubmed
- Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes. (2019) pubmed
- Prenatal betamethasone exposure increases corticotropin-releasing hormone expression along with increased hippocampal slice excitability in the developing hippocampus. (2020) pubmed
- [Prenatal rescue dose of betamethasone in the preterm infant with intrauterine growth restriction]. (2023) pubmed
- Prenatal Administration of Betamethasone and Neonatal Respiratory Distress Syndrome in Multifetal Pregnancies: A Randomized Controlled Trial. (2020) pubmed
- Epileptic spasms in infancy: Transferring rat prenatal betamethasone-postnatal NMDA model to mice. (2023) pubmed
- Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. (2017) pubmed
- Reproductive disorders in female rats after prenatal exposure to betamethasone. (2017) pubmed